A Phase 1, Single-arm, Open-label, Dose-escalation Study of AFP Specific T Cell Receptor Transduced T Cells InjectionHRYZ-T102in Patients With AFP Positive Advanced Hepatocellular Carcinoma and Other Solid Tumors
Latest Information Update: 29 Jul 2024
At a glance
- Drugs HRYZT 102 (Primary) ; Cyclophosphamide; Fludarabine
- Indications Liver cancer; Solid tumours
- Focus Adverse reactions
- Sponsors HengRui YuanZheng Bio-Technology
Most Recent Events
- 29 Jul 2024 New trial record